Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Adolescent male rats release more stress hormones than adults, and testosterone affects them differently.

Acupuncture and herbal treatments effectively reduced hair loss in androgenetic alopecia.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Nocturia cases increased, but medication use declined, suggesting under-treatment.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

δ-GABAA receptors affect alcohol consumption based on the estrous cycle and influence movement regardless of the cycle.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Minoxidil with a diuretic effectively lowers blood pressure in moderately hypertensive men with minimal side effects.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

MR antagonists may improve skin health and wound healing, especially in aging.

Micelles can change cetirizine's ionization, affecting its effectiveness in treatments.

Breast implants are generally safe, but textured implants may rarely cause lymphoma.

Ginkgo biloba has health benefits but also contains toxic compounds, driving interest in its use in medicine and food.

Indian herbal medicine shows promise for treating skin diseases but needs more research to prove effectiveness.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

The roadmap calls for better research and funding to improve PCOS diagnosis, treatment, and health outcomes.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

Alopecia areata greatly affects people's life quality, mental health, and work life.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Follicular unit extraction is an effective hair transplant method for advanced baldness with high patient satisfaction, but some experienced decreased density over time.

New therapies are needed to reduce the burden of alopecia areata.